Nanoengineered Therapeutics for Lung Cancer: Advanced Drug Delivery Strategies explores contemporary methods for diagnosing and treating lung cancer using cutting-edge nanotechnology. The book provides a foundational understanding of lung cancer biology, detailing innovative nanodrug delivery strategies and their practical applications in treatment. The content is strategically structured, covering the design, synthesis, and application of nanodrug delivery systems. Chapters delve into specific technologies such as gold nanoparticles, exosome-mediated therapies, and siRNA-based gene silencing. The book also addresses challenges like drug resistance and toxicity, offering insights into future research directions and advancements in the field. This book benefits graduate students, researchers, and healthcare professionals by seamlessly integrating theoretical concepts with practical applications. It serves as an essential educational resource, equipping readers with the knowledge and skills needed to tackle complex challenges in lung cancer treatment using nanomedicine. This comprehensive guide ensures that readers stay at the forefront of the rapidly evolving landscape of cancer therapeutics.
Sprache
Verlagsort
Verlagsgruppe
Elsevier Science Publishing Co Inc
Zielgruppe
Produkt-Hinweis
Broschur/Paperback
Klebebindung
Maße
Höhe: 235 mm
Breite: 191 mm
Gewicht
ISBN-13
978-0-443-44585-9 (9780443445859)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Klassifikation
Arun Kumar Singh completed his Master of Pharmacy (M. Pharm) in Pharmaceutics from Galgotias University, Greater Noida, India. He is currently an Assistant Professor in the Department of Pharmacy at Vivekanand Global University, where he is actively engaged in teaching and research.
His research interests encompass various emerging and interdisciplinary fields, including nano-formulation, blockchain technology, the Internet of Things (IoT), machine learning, cancer biology, artificial intelligence, big data analytics, and neuroscience. Demonstrating a strong commitment to academic excellence, Mr. Singh has made significant contributions to the scientific community.
Dr. Meenakshi Dhanawat is an Associate Professor at the Amity Institute of Pharmacy, Amity University Haryana, with over 18 years of experience in pharmaceutical sciences. She holds a Master's degree from NIPER Mohali and a Ph.D. from IIT-BHU Varanasi, specializing in medicinal chemistry and CNS drug delivery targeting 5HT1A/2A receptors. Dr. Dhanawat's research spans synthetic and heterocyclic chemistry, nanotechnology, drug delivery systems, prodrug design, and herbal drug extraction. She has published 75 research articles and reviews, holds 5 patents, authored 6 books, contributed 13 book chapters, and edited 5 books. An active participant in national and international conferences, she has received prestigious grants from AAPS, DBT, and DST, along with the Rajiv Gandhi National Fellowship. Dr. Dhanawat's work significantly advances pharmaceutical innovation and education, reflecting her commitment to scientific excellence and mentorship Dr Shikha Baghel Chauhan is working as Associate Professor in Department of Industrial Pharmacy, Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh. She has over 2 decades of experience in both academia and the pharmaceutical industry. She holds a PhD in Pharmaceutics from Amity University, Noida. She is the founder of the popular pharmacy YouTube channel 'Pharmacypedia'. She has published 52 research papers in various international and national journals and has served as the editor of two books with international publishers. She has been granted two patents and has authored nine books with different national and international publishers. Additionally, she has written over 15 book chapters for many prestigious publishers. Her key research areas include Novel Drug Delivery Systems, Transdermal Drug Delivery Systems, Nano Lipid Carriers, and Herbal Drug Development
Dr. Singh has more than 30 years of experience working as a Hematology Scientist and training new employees. He has nearly 20 years of teaching hematology and blood cell morphology to medical and medical laboratory students at Universities and offering continuing professional development blood cell morphology workshops for practicing scientists. Neeraj Kumar is at Thapar Institute of Engineering & Technology, India
Herausgeber*in
Assistant Professor, Department of Pharmacy, Vivekanand Global University Jaipur Rajasthan, India
Amity Institute of Pharmacy, Amity University Haryana, Haryana, India
Amity Institute of Pharmacy, India
Hematology Academic Program Director, Medical laboratory Science Gold Coast Campus, Griffith University, Queensland, Australia
Thapar Institute of Engineering and Technology, India
1. Introduction to Nanomedical Drug Delivery for Lung Cancer
2. An Overview of the Anatomy and Physiology of Lung Cancers
3. Nanoparticle Advancements in Lung Cancer: Cutting-edge Diagnosis and Therapy Approaches
4. Revolutionizing Lung Cancer Treatment: Nanoengineered Enhancements in Targeted Drug Delivery for Enhanced Efficacy
5. Exosome-Mediated Precision Targeting: A Paradigm Shift in Lung Cancer Theranostics
6. Exosome-Mediated Precision Immunotherapy in Lung Cancer: Harnessing Smart Drug Delivery Vehicles
7. Gold Nanoparticles in the Battle Against Lung Cancer: Biomedical Applications and Therapeutic Innovations
8. Nanoparticle Chemotherapy via Pulmonary Route: Addressing Challenges, Exploring Opportunities in Lung Cancer Treatment
9. Targeted Therapeutics: Harnessing Polymeric Nanoparticles for Lung Cancer Treatment
10. Solid Lipid Nanoparticles: Revolutionizing Lung Cancer Therapy Through Targeted Drug Delivery
11. Dendrimers: Promising Nanocarriers for Targeted Delivery in Lung Cancer Treatment
12. Targeting Lung Cancer: Aerosol Delivery of Star Polymer-siRNA Nanoparticles for Tumor Inhibition
13. Revolutionizing Lung Cancer Immunotherapy: siRNA-Based Gene Silencing for Immune Checkpoint Blockade
14. Overcoming Drug Resistance in Non-Small Cell Lung Cancer: siRNA-Guided Gene Silencing Combined with Cisplatin Therapy
15. Navigating Toxicity in Lung Cancer Immunotherapy: Challenges and Advances in Nanomedicine Drug Delivery
16. Nanotechnology in Lung Cancer Therapy: Recent Advancements and Future Perspectives in Drug Delivery Systems
17. Conclusion: Future Directions and Emerging Trends in Nanomedical Drug Delivery for Lung Cancer
